Abstract-Voltage-dependent Ca 2ϩ channel function (Ca v 1.2, L-type Ca 2ϩ channel) is required for cardiac excitationcontraction (E-C) coupling. Ca v 1.2 plays a key role in modulating cardiac function in response to classic signaling pathways, such as the renin-angiotensin system and sympathetic nervous system. Regulation of cardiac contraction by neurotransmitters and hormones is often correlated with Ca v 1.2 current through the actions of cAMP and cGMP. Cardiac cGMP, which activates protein kinase G (PKG), is regulated by nitric oxide (NO), and natriuretic peptides. Although PKG has been reported to activate or inhibit Ca v 1.2 function, it is still unclear whether Ca v 1.2 subunits are PKG substrates. We have identified phosphorylation sites within the ␣ 1c and ␤ 2a subunits that are phosphorylated by PKGI␣ in vitro. We demonstrate that a subset of these phosphorylation sites is modulated, in a cGMP-PKG-specific manner, in intact HEK cells heterologously expressing ␣ 1c and ␤ 2a subunits. Using phospho-epitope-specific antibodies, we show that the phosphorylation of these residues is enhanced by PKG in intact cardiac myocytes. Activation of PKG in HEK cells transfected with ␣ 1c and ␤ 2a subunits caused an inhibition of Ca v 1.2 whole-cell current. PKG-mediated inhibition of Ca v 1.2 current was significantly reduced by coexpression of an alanine-substituted Ca v 1.2 ␤ 2a subunit (Ser 496 ). Our results identify a molecular mechanism by which cGMP-PKG regulates Ca v 1.2 phosphorylation and function. (Circ Res.
Results

Ca v 1.2 ␣ 1 Subunit Is Phosphorylated by PKG
Although prior work has established that cGMP can modulate Ca v 1.2 activity, the targets for PKG within the Ca v 1.2 complex have not been established. To determine whether the ␣ 1c subunit is phosphorylated by PKG, we performed in vitro kinase assays. Immune complexes were isolated with anti-␣ 1c subunit antibody or preimmune serum and subjected to kinase assays with [␥- 32 P] ATP in the absence or presence of cGMP and PKGI␣ ( Figure 1A ; nϭ3). The signal at Ϸ220 kDa indicates that the ␣ 1c subunit is phosphorylated by exogenous PKG in vitro. The signal at Ϸ220 kDa is specific because no signal was detected in the preimmune serum lane. The relatively weak 32 P labeling of ␣ 1c in the absence of exogenous PKG may represent the phosphorylation of ␣ 1c by an associated kinase (Ca v 1.2 associates directly with endogenous PKC␣ in HEK cells 15 ).
To map the PKG phosphorylation sites, we used GST fusion proteins containing nonoverlapping regions of the ␣ 1c intracellular regions as substrates for the in vitro PKG kinase assay. PKG phosphorylated the GST fusion proteins containing the I-II loop and the distal C terminus (1906 -2170) ( Figure 1B ; nϭ4). PKA also phosphorylated the distal C terminus (1906 -2170) but phosphorylated the I-II loop to a lesser extent ( Figure 1C ; nϭ5). An examination of the amino acid sequence within the I-II loop revealed several potential phosphorylation sites. Based on electrophysiological experiments, a potential phosphorylation site (Ser 533 ) within the I-II loop of the ␣ 1c was previously identified. 11 However, biochemical evidence supporting the phosphorylation of this site was not performed. We created, by site-directed mutagenesis, single and double alanine (Ala) substitution mutants of the potential PKG phosphorylation residues within the I-II loop. Radiolabeling of the GST I-II loop fusion protein was significantly reduced by Ala-substitution of either Ser 528 or Ser 533 , and was completely abrogated by the double Ala mutation ( Figure 2B ). In contrast, Ala-substitution of Ser 530 alone caused an increase in the radiolabeling of the GST fusion protein. We developed phospho-epitope specific-antibodies, designed to report the phosphorylation of either Ser 528 (pS528) or Ser 533 (pS533). The antibodies immunodetected the appropriate phosphorylated residue ( Figure 2C ). In contrast, no anti-phospho-Ser 528 antibody immunoreactivity was detected when a single substitution (S528A) was introduced into the substrate sequence. The pS533 antibody weakly recognized the I-II loop, under nonphosphorylated conditions, but the signal did not substantially increase after PKG phosphorylation of an alaninesubstituted GST fusion protein. These results suggest that both Ser 528 and Ser 533 are potential ␣ 1c PKG phosphorylation sites, and that we have developed appropriate reagents to detect the phosphorylation of these residues in full-length channel and in intact cells.
␣ 1c Ser 1928 Is a PKG Phosphorylation Site
Previous studies have mapped PKA 12, 13 and PKC 15 phosphorylation sites on the ␣ 1c subunit to a consensus site (RRAS 1928 ) within the distal C-terminus. Ser 1928 also represents a consensus PKG phosphorylation site. PKG induced significant 32 P-ATP incorporation into the GST-fused wild-type fragment, but radiolabeling was completely abrogated by a single Ala substitution (S1928A; Figure 2D ). Similarly, using a phospho-epitope-specific antibody that we have previously developed, 15 prominent immunoreactive bands were detected (with a range of mobilities corresponding to full-length and truncated fragments; Figure 2E ). No anti-phospho-Ser 1928 antibody immunoreactivity was detected when a single substitution (S1928A) was introduced into the substrate sequence. Having validated the specificity of the antibodies pS528, pS533, and pS1928, as reagents to track the PKG-dependent phosphorylation of the ␣ 1c subunit, we used them to examine the phosphorylation status of full-length recombinant wildtype and Ala-substituted mutants ␣ 1c , coexpressed with the ␤ 2a subunit in HEK cells. Wild-type and Ala-substituted ␣ 1c mutants were immunoprecipitated by anti-␣ 1c antibody from the HEK cells extracts ( Figure 3A ) or rat heart ( Figure 3B ) and subjected to the PKG in vitro kinase assay. In contrast to the GST fusion protein results, only Ser 1928 demonstrated significant PKG phosphorylation ( Figure 3A ). Possible explanations for the lack of PKG phosphorylation of Ser 528 and Ser 533 in full-length recombinant ␣ 1c , as compared with the GST fusion proteins, is the coexpression of the ␤ 2a subunit, which may sterically block access to PKG. Ca v 1.2 ␤ subunits bind to the ␣ 1c I-II loop. 16 The ␣-interaction domain (AID), however, does not overlap with the identified PKG phosphorylation residues. We found that Ser 528 or Ser 533 was not phosphorylated in full-length channel expressed in HEK cells in the absence of ␤ 2 subunit (data not shown). Moreover, PKG failed to phosphorylate Ser 528 and Ser 533 in ␣ 1c immunoprecipitated from rat heart ( Figure 3B ). It is possible that the I-II loop adopts a different conformation in full-length channel, which alters the PKG phosphorylation of these residues.
Ca v 1.2 ␤ 2 Subunit Is Phosphorylated by PKG
We divided the rabbit ␤ 2a into amino terminus (NT; amino acid residues 1 to 412) and carboxy terminus (CT; amino acid residues 413 to 606) fragments, expressed each as GST fusion proteins in E coli and purified the protein on glutathione sepharose. GST-NT-␤ 2 and GST-CT-␤ 2 fusion proteins were subjected to in vitro kinase assays with [␥-32 P] ATP. Figure  4A shows that both proteins were labeled in the in vitro kinase assay by PKG. However, the CT fusion protein contained Ϸ90% of the total 32 P incorporation (based on densitometry of the 32 P incorporated into the CT protein divided by the total 32 P incorporated into both NT [PKG autophosphorylation subtracted] and CT proteins normalized for the amount of protein on Coomassie stain; nϭ3). To identify the phosphorylation site within the CT fragment, MALDI analysis was performed of the trypsin-digested Figure 4D ). The antibody is specific, as immunoreactivity was not present in PKG-phosphorylated full-length alanine-substituted ␤ 2a subunit ( Figure 4D ). Ser 496 is not phosphorylated by PKA ( Figure 4D ), consistent with a prior report demonstrating that the PKA phosphorylation sites in Ca v 1.2 ␤ 2a are Ser 459 , Figure 3 . Ser 1928 is phosphorylated by PKG in full-length recombinant and native cardiac channels. Extracts from HEK cells transfected with WT or S1928A, S528A, or S533A (A) or heart (B) were prepared, followed by preimmune or ␣ 1c immunoprecipitation and kinase reaction as indicated. Samples were size-fractionated on SDS-polyacrylamide gel, transferred to nitrocellulose membrane, and probed with antiphospho-Ser Figure 5A and 5B). Phosphorylation of ␣ 1c and ␤ 2a is dependent on cGMP-induced activation of PKGI␣, because cGMP-induced phosphorylation above basal levels could not be demonstrated with the expression of a dominant negative catalytic-inactive PKGI␣ mutant (K390R; Figure 5A and 5B). Exposure of the cells to a relatively low concentration of calyculin A (10 nmol/L) slightly increased the phosphorylation of ␣ 1c Ser 1928 , as previously reported 15 ( Figure 5A ). In contrast, exposure of the cells to calyculin A (10 nmol/L) alone did not increase the phosphorylation of ␤ 2a Ser 496 ( Figure 5B). The detection of ␣ 1c Ser 1928 and ␤ 2a Ser 496 was specific, as Ala-substitution of either residue caused loss of immunoreactivity ( Figure 5A and 5B).
PKG expression is developmentally regulated in the heart, with highest expression in the newborn compared with adult ventricular myocytes. 20 Several studies have shown that PKG is expressed in the adult rat heart and in isolated adult rat ventricular myocytes. [21] [22] [23] Immunoblotting experiments with homogenates prepared from isolated neonatal and adult rat ventricular myocytes showed that PKG is present in appreciable amounts in isolated rat adult and neonatal ventricular myocytes ( Figure 6A) 
Electrophysiological Analysis in HEK Cells
There is a lack of consensus on the precise role of PKGI in modulating Ca v 1.2 function in cardiac myocytes, with reports suggesting that cGMP-induced activation of PKG causes Ca v 1.2 current facilitation, inhibition, or even both. 1-4,7,29 -34 cGMP-PKG has been shown to inhibit both basal Ca v 1.2 current and ␤-adrenergic-mediated upregulation of Ca v 1.2 current. [35] [36] [37] To explore the effect of PKG phosphorylation of Ca v 1.2, we coexpressed wild-type (WT) ␣ 1c , ␤ 2a , and PKGI␣ in HEK293 cells. After obtaining a stable baseline peak Ba 2ϩ current (assessed at ϩ10 mV every 10 sec) in whole cell configuration, we exposed the cell to calyculin A or 8Br-cGMPϩcalyculin A. Peak Ca v 1.2 current amplitude (at ϩ10 mV) remained relatively stable during the experimental period in the absence of cGMPϩcalyculin, with Ͻ10% run-down during the first 3 minutes ( Figure 7A, 7D, and 7G) . Activation of PKG significantly reduced the amplitude of peak Ca v 1.2 current to 88.5Ϯ3% of control at 1 minute, to 81Ϯ3.8% of control at 2 minutes, and 75Ϯ4.1% of control at 3 minutes ( Figure 7C , 7F, and 7I; nϭ8; PϽ0.01 for 1 and 2 minutes, PϽ0.05 for 3 minutes compared with control and calyculin-treated cells). PKGmodulation of Ca v 1.2 did not shift the current-voltage relationship (supplemental Figure IB) . We studied the effect of Ala-substitution of the PKG phosphorylation sites on ␣ 1c and ␤ 2a . Under basal conditions, the current density and the current-voltage relationship among the mutants were comparable (supplemental Figure IA through IF) . A prior report suggested that the PKG-mediated inhibition of Ca v 1.2 expressed in Xenopus oocytes was dependent on the presence ␣ 1c Ser
533
. 11 Consistent with the biochemical data showing that ␣ 1c Ser 533 was not phosphorylated in full-length channel (Figure 3 ), Ala-substitution of Ser 533 did not reduce PKG-mediated inhibition of peak Ca v 1.2 in HEK cells ( Figure  8A , 8E, and 8I). Similarly, Ala-substitution of ␣ 1c Ser 1928 did not reduce PKG-mediated inhibition ( Figure 8B , 8F, and 8J), consistent with the premise that phosphorylation of Ser 1928 may be responsible for a small increase in Ca v 1.2 current in response to ␤-adrenergic stimulation. 25 In contrast, coexpression of the mutant ␤ 2a harboring an Ala-substitution at Ser 496 prevented the PKG-mediated inhibition of Ca v 1.2 after exposure to 8Br-cGMP and calyculin ( Figure 8C , 8G, and 8K; nϭ8, PϽ0.01 compared with cGMPϩcalyculin-treated wild-type at 1, 2, and 3 minutes). Similarly, coexpression of the ␣ 1c harboring an Ala-substitution of Ser 1928 and ␤ 2a harboring the Ala-substitution of Ser 496 essentially eliminated the PKG-mediated inhibition of Ca v 1.2 ( Figure 8D , 8H, and 8L; nϭ5; PϽ0.01 compared with cGMPϩcalyculin-treated wild-type at 1, 2, and 3 minutes).
Discussion
Several approaches have been taken to elucidate the regulatory domains within Ca v 1.2, predominantly involving identification of potential consensus phosphorylation sites, and then studying the electrophysiological effects of phosphorylation site mutations. Although potentially informative, this approach does not prove that the site is actually phosphorylated in a cellular context, as unanticipated changes in the secondary structure of the channel may produce changes in the electrophysiological properties of the channel. The rabbit ␣ 1c sequence has several consensus PKG phosphorylation sites in extracellular domains, which complicates identification of phosphorylation sites using full-length protein. Using GST fusion proteins incorporating intracellular domains of the ␣ 1c subunit, we identified 3 residues, 2 within the I-II loop and 1 within the C terminus of the ␣ 1c subunit, which are phosphorylated by PKG in vitro. However, the 2 residues within the I-II loop (Ser 528 and Ser 533 ) were not phosphorylated in full-length channel. Although puzzling, the absence of PKG phosphorylation of these residues in full-length channel was not attributable to the ␤ subunit sterically blocking access to these residues. Other explanations for this finding are that access to the residues is blocked by other domains of the ␣ 1 subunit, or that a change in conformation of the I-II loop in full-length channel alters the ability of PKG to phosphorylate these residues.
Wray and colleagues 11 attributed the PKG-mediated inhibition of Ca v 1.2 activity to the phosphorylation of Ser 533 within the ␣ 1c I-II loop. Although Ser 533 is PKG phosphorylated in a GST fusion protein comprising the I-II loop, we were unable to demonstrate its phosphorylation (using a phospho-epitope-specific antibody) in full-length recombinant channels or in native ␣ 1c , immunoprecipitated from rat heart, and Ala-substitution of Ser 533 did not prevent cGMPϩcalcyculin-mediated reduction of peak current. In contrast, 2 residues, ␣ 1c -Ser 1928 and ␤ 2a -Ser, 496 are phosphorylated in full-length recombinant channels and in protein isolated from heart, and these residues are modulated biochemically in a cellular context by 8Br-cGMP.
Using conditions that optimally permit phosphorylation of these residues (assessed biochemically), we sought to determine whether the residues identified in our biochemical screen were required for PKG-mediated inhibition of channel activity. We found that Ala-substitution of ␤ 2a -Ser 496 significantly reduced PKG-mediated inhibition of channel activity in HEK cells. Ser 1928 is the only identified PKA phosphorylation site on ␣ 1c subunit, and its phosphorylation was felt to be responsible, in part, for the PKA-induced upregulation of channel activity in response to ␤-adrenergic stimulation. 38 However, the requirement for Ser 1928 phosphorylation in mediating ␤-adrenergic-mediated upregulation has been questioned, 39 supported by the recent work from the O'Rourke group using virally-infected cardiomyocytes. 40 In myocytes, transfected Ala-substituted Ser 1928 Ca v 1.2 channels were still regulated by ␤-adrenergic stimulation, although the stimulated Ca 2ϩ current was 70% to 80% of that observed with wild-type channels. 25, 40 Assessing the role of Ser Studies on the effects of cGMP-PKG on Ca v 1.2 current have shown variable effects. Many studies have reported that cGMP opposes the ␤-adrenergic receptor/cAMP-induced increase in Ca v 1.2 current and cardiac contractility. 2, [41] [42] [43] NO and acetylcholine were proposed to share a common cGMP-dependent signaling pathways, although studies using endothelial NO synthase knockout mice and PKGI knockout mice have suggested that perhaps effects of acetylcholine are not PKGdependent. 35, 44, 45 Using a PKGI transgenic mouse, PKGI was shown to be an important downstream target for NO/cGMP-but not muscarinic-induced inhibition of single Ca v 1.2 currents in cardiac myocytes. 35 In wild-type cardiac myocytes, basal Ca v 1.2-gating properties were not controlled by NO and cGMP, whereas in the PKGI transgenic mice, basal Ca v 1.2 peak average current, mean open probability, and availability were reduced by NO and cGMP. 35 This indicates that PKG-mediated modulation of basal Ca v 1.2 activity depends on the intracellular concentration of PKGI. In contrast, isoproterenol-stimulated Ca v 1.2 was suppressed by NO and cGMP in both wild-type and PKGI-TG cardiac myocytes. 35 In conclusion, we have pinpointed the residues within the Ca v 1.2 (␣ 1c ϩ␤ 2 ) complex, which are modulated by cGMP-PKG signaling pathways. Using phospho-epitope specific antibodies designed to recognize the phosphorylation of specific Ca v 1.2 residues, we have demonstrated that Ca v 1.2 is directly phosphorylated by PKG. (Invitrogen). The preparation of the rabbit α 1c GST fusion proteins was described previously 1 .
Immunoblots: For immunoblots, proteins were transferred to nitrocellulose membrane, and probed with the phospho-specific and general antibodies, followed by anti-rabbit HRP-conjugated secondary antibody and ECL (Pierce). Detection was performed with a CCD camera (Alpha Innotech Corporation) or film. Image quantification was performed using ImageQuant software.
PKA kinase assay-GST fusion proteins were purified with glutathione-sepharose. Sepharose beads were extensively washed and resuspended in kinase reaction buffer containing (in mM), 8 MgCl, 10 EGTA, 50 Tris, 50 PIPES; pH 6.8. Phosphorylation reactions were initiated with the addition of PKA c (5 units, Sigma), MgATP (50 µM) and 32 P-γATP (5 µCi). Reactions were terminated with 6X loading buffer, size-fractionated on SDS-PAGE and exposed to film. For immunoblots, gels were transferred to nitrocellulose and probed with phospho-specific antibodies. All in vitro PKA kinase assays were repeated at least three times.
PKG kinase assay-The PKG kinase assay was carried in the phosphorylation buffer (20 mM Tris; pH7.5, 20mM MgAc, 2 mM DTT, 20 µM cGMP) and 50 µM ATP with or without 5 µCi of relationship was determined with 250-ms step depolarizations (-50 to +60 mV) from a -60 mV holding potential. The effect of 8Br-GMP was examined 2-3 minutes after establishing whole cell configuration, ensuring a stable baseline (for at least 30 seconds) before initiating the experiment.
All cells without a stable baseline (potentially due to run-down) were not studied. Statistical significance was determined using an unpaired and paired Student's t test. 
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